Skip to main content
Sage Choice logoLink to Sage Choice
. 2015 Oct 27;21(3):209–211. doi: 10.1177/1355819615612510

Evaluation of public involvement in research: time for a major re-think?

Natalie Edelman 1,, Duncan Barron 1
PMCID: PMC4904347  PMID: 26510440

Abstract

The way that public involvement in research has been evaluated as a complex intervention has derailed the development of an evidence base. Two alternative approaches are available for constructing and evaluating patient involvement, each of which requires us to revisit the purposes and values that underpin it in each stage of the research process.

Keywords: public involvement, evaluation, complex intervention

Background

Public involvement (PI) in research has been defined as ‘research being carried out with or by members of the public rather than to, about or for them as mere research participants’.1 PI in research often refers to consultation or collaboration with lay people on activities such as choosing which outcomes to measure, designing recruitment materials and presenting findings.

Increasingly, PI is mandated by many institutions involved in health and social care research, dovetailing with movements towards PI in health care and the patient as consumer.2 Research funders in the UK commonly require applicants to detail how PI has, and will continue to, inform their proposed research.3,4

Difficulties in evaluating the benefits of public involvement

Considerable guidance is available57 on how to undertake PI, largely based on grey literature and qualitative research. This has identified important issues around tokenism and the well-being of lay people in research environments.8 More problematic has been the development of an evidence base of the impact of PI on research, fuelled by rhetoric such as:‘ … active involvement of the public in the research process leads to research that is more relevant to people and is more likely to be used’.9

Such statements present a consequentialist rationale for PI,10 one in which PI is endorsed as morally right based on its beneficial consequences in improving the quality and relevance of research. This rationale has been presented as instrumental,11 pragmatic,12 and the methodological argument.2,13,14

Reviews of empirical work do suggest PI can improve the quality, relevance and ethical conduct of research.6,1517 Nonetheless, the quest for evidence of such benefit has been difficult, prompting suggestions that academics have failed in this regard.18

We propose four key reasons for these difficulties. Firstly, the entire consequentialist rationale for PI in research is contested by those proposing a deontological rationale (i.e. giving rightful voice and power to those at the heart of health care). This rationale has been termed ideological,12 moralistic19 and the moral and ethical perspective,2,13 its position summed up as: ‘defining consumer involvement outcomes solely in terms of research quality ignores the rights of those being researched or likely to benefit from the research’.13

Secondly, there is contention about what types of impact such as improved study recruitment rates are worth investigating for whom, when and why.20 Similarly, disagreement persists about which indicators and methods can and should be used, with concerns about weak study designs.21 But most importantly, underpinning these disagreements is a trend towards evaluating PI in the same manner as one would evaluate therapeutic interventions such as surgical procedures, drugs or screening programmes.

Evaluating public involvement as if it were a therapeutic intervention

Much clinical and health services research concerns the evaluation of therapeutic interventions and employs a variety of research methods and processes to do so. PI is a component of the research process, i.e. the activities of research funding, design, conduct, analysis and dissemination. Yet instead of evaluating PI as part of the research process it is commonly evaluated as if it were itself a therapeutic intervention. This approach, which tends towards defining and evaluating PI as a complex intervention22,23 or complex social intervention,7 is the reason why evaluation has proved difficult.

Complex interventions comprise two or more active components (e.g. medication plus adherence counselling). Their evaluation often includes process evaluation, comparison of outcomes between those receiving and not receiving the intervention, and realist evaluation. The latter emphasizes the context of delivery and has been recommended and used for PI in studies in the UK funded by the National Institute of Health Research with INVOLVE13,24 and the Medical Research Council.2527

This trend has arisen because of the complexity and importance of context regarding PI in research.13 However, this has also created a misconstruction of PI in research, using unsuitable methods such as realist evaluation.24 This has derailed the development of a meaningful and robust evidence base. In place of evaluating (and hence implicitly constructing) PI as if it were a therapeutic intervention, alternative constructions of PI are needed from which approaches to evaluation will then follow.

Alternative constructions of public involvement in research

If we reject the construction of PI as an intervention and recognize it as part of the research process, what alternative constructions exist? From a deontological perspective we might construct PI as a contribution of expertise and advocacy, equitable to the contribution of clinicians, statisticians or others. Therefore, we might focus evaluation on the processes by which: the purposes of PI in a given scenario can be made explicit; lay knowledge can be brought forth and integrated with other expert knowledge; and advocacy and accountability for and by all parties can best be achieved. (The notion of advocacy also lies at the heart of controversy about training lay people in research methods,28 in which the implicit concern is whether one can advocate for lay people having adopted the interests of the researcher through training.)

Alternatively, we might adopt a consequentialist rationale, constructing PI in research as a methodological activity to improve research quality and drawing inspiration from evaluation of research methods. Such evaluation usually comprises critique of their congruence with stated purpose and theory. Crucially, research methods are not tested against pre-determined outcomes in the manner that we would evaluate a complex intervention, and in which PI is commonly evaluated.

Conclusions

Theorization of PI has tended towards an internal focus,29 categorizing levels of power and responsibility. However, we also need to theorize the nature and purposes of PI in relation to the overarching aims and processes of health research. Different purposes and constructions of PI may suit different stages of the research process. For example, the purpose of lay representation on a generic research funding panel may be public accountability – best served by a deontological construction of PI as public advocacy. In contrast, the purpose of lay involvement in study design may be to improve the quality of the research regarding such aspects as recruitment, attrition and patient-centred outcomes. This may be best served by a consequentialist construction of PI as a methodological activity.

PI in research cannot – and should not – be evaluated as an intervention but rather as part of the research process. Alternative constructions of PI, that acknowledge this, are possible. Chiming with recent calls for the development of common goals for PI in research,18,29 we must revisit its values and purposes. This would provide the foundations for identifying constructions that allow meaningful evaluation of those intentions and by appropriate means.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

  • 1.INVOLVE. What is public involvement in research? INVOLVE 2012, http://www.invo.org.uk/find-out-more/what-is-public-involvement-in-research-2/ (2014, accessed 25 November 2014).
  • 2.Ward PR, Thompson J, Barber R, et al. Critical perspectives on ‘consumer involvement' in health research. J Sociol 2009; 46: 1–20. [Google Scholar]
  • 3.Gamble C, Dudley L, Allam A, et al. Patient and public involvement in the early stages of clinical trial development: a systematic cohort investigation. BMJ Open 2014; 4: e005234–e005234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Robinson L, Newton J, Dawson P. Professionals and the public: power or partnership in health research? J Eval Clin Pract 2010; 18: 276–282. [DOI] [PubMed] [Google Scholar]
  • 5.Petit-Zeman S, Locock L. Bring on the evidence. Nature 2013; 501: 160–161. [DOI] [PubMed] [Google Scholar]
  • 6.Staley K. Exploring impact: public involvement in NHS, public health and social care research, Eastleigh, UK: INVOLVE, 2009. [Google Scholar]
  • 7.Staley K, Buckland SA, Hayes H, et al. ‘The missing links': understanding how context and mechanism influence the impact of public involvement in research. Health Expect 2012; 17(6): 755–764. [DOI] [PMC free article] [PubMed]
  • 8.Fudge N, Wolfe CD, McKevitt C. Assessing the promise of user involvement in health service development: ethnographic study. BMJ (Clin Res Ed) 2008; 336: 313–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.INVOLVE. The impact of public involvement on research: a discussion paper from the INVOLVE Evidence, Knowledge and Learning working group, Eastleigh, Yorkshire: INVOLVE, 2007. [Google Scholar]
  • 10.Boote J, Baird W, Sutton A. Public involvement in the systematic review process in health and social care: a narrative review of case examples. Health Policy 2011; 102: 105–116. [DOI] [PubMed] [Google Scholar]
  • 11.Carter P, Beech R, Coxon D, et al. Mobilising the knowledge of clinicians and patients for applied health research. Contemp Soc Sci 2013; 8: 307–320. [Google Scholar]
  • 12.Wright D, Foster C, Amir Z, et al. Critical appraisal guidelines for assessing the quality and impact of user involvement in research. Health Expect 2010; 13: 359–368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mathie E, Wilson P, Poland F, et al. Consumer involvement in health research: a UK scoping and survey. Int J Consumer Stud 2014; 38: 35–44. [Google Scholar]
  • 14.Telford R, Boote JD, Cooper CL. What does it mean to involve consumers successfully in NHS research? A consensus study. Health Expect 2004; 7: 209–220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Brett J, Staniszewska S, Mockford C, et al. The PIRICOM Study. A systematic review of the conceptualisation, measurement, impact and outcomes of patient and public involvement in health and social care research, London: United Kingdom Clinical Research Collaboration, 2010. [Google Scholar]
  • 16.INVOLVE. Patient and public involvement in research and research ethics committee review, Eastleigh: INVOLVE, 2009. [Google Scholar]
  • 17.Staley K, Minogue V. User involvement leads to more ethically sound research. Clin Ethics 2006; 1: 95–100. [Google Scholar]
  • 18.Denegri S (ed). NIHR strategic review of public involvement in research – “breaking boundaries”. In: Public involvement in research: changing landscapes, Birmingham, 26–27 November 2014.
  • 19.Boote J, Baird W, Beecroft C. Public involvement at the design stage of primary health research: a narrative review of case examples. Health Policy 2010; 95: 10–23. [DOI] [PubMed] [Google Scholar]
  • 20.Staniszewska S, Brett J, Mockford C, et al. The GRIPP checklist: strengthening the quality of patient and public involvement reporting in research. Int J Technol Assess Health Care 2011; 27: 391–399. [DOI] [PubMed] [Google Scholar]
  • 21.Boote J, Telford R, Cooper CL. Consumer involvement in health research: a review and research agenda. Health Policy 2002; 61: 213–236. [DOI] [PubMed] [Google Scholar]
  • 22.Boote J. Towards a new research agenda for PPI: an overview of the journey travelled, and consideration of where we may want to go next. In: Patient, carer and public involvement seminar ‘Moving from project-led PPI to research-led PPI', 14 May 2013, University of Leeds, National Institute for Health Research.
  • 23.Petticrew M. INVONET workshop 2008, 13 February 2008, London: INVOLVE.
  • 24.Evans D. Patient and public involvement in research in the English NHS: a documentary analysis of the complex interplay of evidence and policy. Evidence Policy: J Res, Debate Pract 2014; 10: 361–377. [Google Scholar]
  • 25.Gradinger F, Britten N, Wyatt K, et al. Values associated with public involvement in health and social care research: a narrative review. Health Expect 2013; 18(5): 661–675. [DOI] [PMC free article] [PubMed]
  • 26.Snape D, Kirkham J, Britten N, et al. Exploring perceived barriers, drivers, impacts and the need for evaluation of public involvement in health and social care research: a modified Delphi study. BMJ Open 2014; 4: e004943–e004943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Snape D, Kirkham J, Preston J, et al. Exploring areas of consensus and conflict around values underpinning public involvement in health and social care research: a modified Delphi study. BMJ Open 2014; 4: e004217–e004217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ives J, Damery S and Redwod S. PPI, paradoxes and Plato: who's sailing the ship? J Med Ethics 2013; 39: 181–185. [DOI] [PubMed]
  • 29.INVOLVE. Values, principles and standards for public involvement in research. INVOLVE, 2014 27 October 2014.
  • 30.Oliver SR, Rees RW, Clarke-Jones L, et al. A multidimensional conceptual framework for analysing public involvement in health services research. Health Expectations 2008; 111: 72–84. [DOI] [PMC free article] [PubMed]

Articles from Journal of Health Services Research & Policy are provided here courtesy of SAGE Publications

RESOURCES